Dissolution [Dissolution / BCS / IVIVC]

posted by jag009  – NJ, 2014-08-22 18:47 (3974 d 04:57 ago) – Posting: # 13419
Views: 9,451

Guys and Girls,

A question... Suppose you have an IR drug product which is highly soluble but poor in permeability and has a Tmax of 8 hrs. Do you think slowing down the rate of in-vitro release will affect the overall PK?

Assume this scenario...
Under the same dissolution medium, assuming the reference is releasing no less than 80% at 30 mins, and your product is releasing no less than 80% at 60 mins. What do you think?

Thanks
John

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,694 registered users;
69 visitors (0 registered, 69 guests [including 16 identified bots]).
Forum time: 23:45 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5